Drug Trial Radar · NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
550
Planned (sponsor's estimate)
Start
May 21, 2024
Primary completion
Apr 3, 2034
Study completion Oct 2, 2034
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Nov 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).
Conditions
- Systemic Lupus Erythematosus
Interventions
PlaceboDrug
Placebo s.c. monthly
IanalumabDrug
Ianalumab s.c. monthly Ianalumab s.c. quarterly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of treatment-emergent Adverse events/Serious Adverse eventsTime frame: through study completion, up to approximately 324 weeks
Locations
167 sites in 29 countries. Site status is shown where the registry gives one.
Pinnacle Research Group Llc
Anniston, Alabama · Recruiting
Providence Medical Center
Burbank, California · Recruiting
Advanced Medical Research
La Palma, California · Recruiting
Millennium Clinical Trials
Westlake Village, California · Active not recruiting
University of Colorado Denver
Aurora, Colorado · Recruiting
Clinical Res Of W Florida
Clearwater, Florida · Recruiting
GNP Research
Cooper City, Florida · Recruiting
Homestead Assoc In Research Inc
Homestead, Florida · Recruiting
IRIS Research and Development
Plantation, Florida · Recruiting
Clinical Research of West Florida Inc
Tampa, Florida · Recruiting
Parris and Associates Rheumatology
Lawrenceville, Georgia · Recruiting
Robert A Hozman MD SC
Skokie, Illinois · Completed
Willow Rheumatology Wellness
Willowbrook, Illinois · Recruiting
Accurate Clinical Research
Lake Charles, Louisiana · Recruiting
UMC New Orleans
New Orleans, Louisiana · Active not recruiting
University Of Maryland
Baltimore, Maryland · Active not recruiting
Henry Ford Health
Detroit, Michigan · Recruiting
Ahmed Arif Medical Research Center
Grand Blanc, Michigan · Recruiting
Paramount Med Rsrch and Consult LLC
Middleburg Heights, Ohio · Recruiting
University Of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
West Tennessee Research Institute
Jackson, Tennessee · Recruiting
Shelby Research LLC
Memphis, Tennessee · Recruiting
Novel Research LLC
Bellaire, Texas · Recruiting
Accurate Clinical Research
League City, Texas · Recruiting
Epic Medical Research
Red Oak, Texas · Recruiting
Novartis Investigative Site
Caba, Argentina · Active not recruiting
Novartis Investigative Site
Caba, Argentina · Recruiting
Novartis Investigative Site
San Miguel de Tucumán, Argentina · Active not recruiting
Novartis Investigative Site
La Plata, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
Quilmes, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
San Miguel, Buenos Aires, Argentina · Active not recruiting
Novartis Investigative Site
San Miguel, Tucumán Province, Argentina · Active not recruiting
Novartis Investigative Site
Maroochydore, Queensland, Australia · Recruiting
Novartis Investigative Site
Salvador, Brazil · Recruiting
Novartis Investigative Site
Vitória, Espírito Santo, Brazil · Recruiting
Novartis Investigative Site
Salvador, Estado de Bahia, Brazil · Recruiting
Novartis Investigative Site
Belo Horizonte, Minas Gerais, Brazil · Active not recruiting
Novartis Investigative Site
Curitiba, Paraná, Brazil · Recruiting
Novartis Investigative Site
Niterói, Rio de Janeiro, Brazil · Active not recruiting
Novartis Investigative Site
Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting
Showing 40 of 167 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.